5FB-12416-06110
3 vaccinations
2 coded responses
4 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 900 / CA
- Registered
- 2021-05-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Dose 2 — Pfizer-BioNTech
-
2021-05-10
Registered in v-safe
- 2021-06-16
-
2021-09-17
Survey response — 6 months, dose 2MedDRA: Norovirus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: NorovirusMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-09-20
-
2021-12-07
Dose 3 — Moderna
- 2022-03-19
-
2022-06-07
Survey response — 6 months, dose 3MedDRA: Arthralgia, Eczema, Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Joint pain. Eczema. Rashes. · Healthcare visit (other): Family doctorMedDRA releases: 2024-11 · check-in free text available
-
2022-06-07
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-17 | Successful | Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-06-07 | Successful 2022-06-08 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — 6 months, dose 2
Symptoms: Norovirus
Release 11 — 6 months, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release